A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC
Clinical trial NCT05773105 · COMPLETED
Trial details
- NCT number
- NCT05773105
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-19
- Primary completion
- 2026-03-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.